Loading patent…
AssigneeMERZ PHARMA GmbH & CO. KGaA
InventorsSusanna Roll, Meik Sladek, Thorin Geister, Irena Pulte, Petra Weissenberger, Gudrun Klein
Estimating the term…
The present invention relates the use of botulinum toxin for the treatment of facial wrinkles, wherein botulinum toxin is administered at high doses (e.g., 50 U to 200 U) using small injection volumes (e.g., 0.05 ml to 0.35 ml). Furthermore, the present invention relates to a method for the treatment of facial wrinkles (e.g., glabellar frown lines) by injecting small volumes of a highly concentrated botulinum toxin solution into a target facial area of a subject.
A method of treating facial wrinkles comprising injecting botulinum toxin in a facial area of a subject at a total dose of 50 U to 200 U and a total volume of 0.05 ml to 0.35 ml to treat said facial wrinkles,
Dependencies are inferred from the claim text.